Literature DB >> 12060750

Mutational switch of an IL-6 response to an interferon-gamma-like response.

Ana P Costa-Pereira1, Silvia Tininini, Birgit Strobl, Tonino Alonzi, Joerg F Schlaak, Hayaatun Is'harc, Ida Gesualdo, Sally J Newman, Ian M Kerr, Valeria Poli.   

Abstract

Signaling through Janus kinases (JAKs) and signal transducers and activators of transcription (STATs) is central to the responses to the majority of cytokines and some growth factors, including the interferons (IFNs) and the IL-6 family of cytokines. The biological responses to stimulation through the widely distributed IL-6 and IFN-gamma receptors are, however, completely different. Remarkably, it is shown here that, in mouse embryo fibroblasts lacking STAT3, IL-6 mediates an IFN-gamma-like response including prolonged activation of STAT1, the induction of multiple IFN-gamma-inducible genes, the expression of class II MHC antigens, and an antiviral state. Normal cells exposed to IL-6 thus require a STAT3-dependent function(s) to down-regulate STAT1 activity and prevent an IFN-gamma-like response. The data encourage the view that the very disparate IFN-gamma and IL-6 JAK/receptor complexes mediate a common set of generic or "core" signals which are subject to STAT3-dependent modulation to provide IL-6 specificity. The switching of one cytokine response to one closely mimicking another as a result of the loss of a single signaling component has profound implications, for example, for the interpretation of the phenotypes of knockout mice and for the clinical use of inhibitors of signaling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12060750      PMCID: PMC123017          DOI: 10.1073/pnas.122236099

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Biologic consequences of Stat1-independent IFN signaling.

Authors:  M P Gil; E Bohn; A K O'Guin; C V Ramana; B Levine; G R Stark; H W Virgin; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

2.  Stat1-independent regulation of gene expression in response to IFN-gamma.

Authors:  C V Ramana; M P Gil; Y Han; R M Ransohoff; R D Schreiber; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

3.  STAT1 from the cell membrane to the DNA.

Authors:  B F Lillemeier; M Köster; I M Kerr
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

4.  Roles of phosphatidylinositol 3-kinase in interferon-gamma-dependent phosphorylation of STAT1 on serine 727 and activation of gene expression.

Authors:  H Nguyen; C V Ramana; J Bayes; G R Stark
Journal:  J Biol Chem       Date:  2001-07-03       Impact factor: 5.157

5.  Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver.

Authors:  T Alonzi; D Maritano; B Gorgoni; G Rizzuto; C Libert; V Poli
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

6.  The distal region and receptor tyrosines of the Epo receptor are non-essential for in vivo erythropoiesis.

Authors:  H Zang; K Sato; H Nakajima; C McKay; P A Ney; J N Ihle
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

7.  Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1.

Authors:  Sean Diehl; J Anguita; A Hoffmeyer; T Zapton; J N Ihle; E Fikrig; M Rincón
Journal:  Immunity       Date:  2000-12       Impact factor: 31.745

8.  Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-gamma uses a different signaling pathway.

Authors:  P Kovarik; D Stoiber; P A Eyers; R Menghini; A Neininger; M Gaestel; P Cohen; T Decker
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 9.  STAT proteins: novel molecular targets for cancer drug discovery.

Authors:  J Turkson; R Jove
Journal:  Oncogene       Date:  2000-12-27       Impact factor: 9.867

10.  Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines.

Authors:  G J TODARO; H GREEN
Journal:  J Cell Biol       Date:  1963-05       Impact factor: 10.539

View more
  105 in total

1.  STAT1 deficiency unexpectedly and markedly exacerbates the pathophysiological actions of IFN-alpha in the central nervous system.

Authors:  Jianping Wang; Robert D Schreiber; Iain L Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-02       Impact factor: 11.205

2.  Stat1 and Stat2 but not Stat3 arbitrate contradictory growth signals elicited by alpha/beta interferon in T lymphocytes.

Authors:  Ramon Gimeno; Chien-Kuo Lee; Christian Schindler; David E Levy
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

3.  Genome-wide discovery of functional transcription factor binding sites by comparative genomics: the case of Stat3.

Authors:  Francesco Vallania; Davide Schiavone; Sarah Dewilde; Emanuela Pupo; Serge Garbay; Raffaele Calogero; Marco Pontoglio; Paolo Provero; Valeria Poli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-12       Impact factor: 11.205

Review 4.  Integration of cytokine and heterologous receptor signaling pathways.

Authors:  Jelena S Bezbradica; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2009-03-19       Impact factor: 25.606

5.  Competitive binding of STATs to receptor phospho-Tyr motifs accounts for altered cytokine responses.

Authors:  Stephan Wilmes; Polly-Anne Jeffrey; Jonathan Martinez-Fabregas; Maximillian Hafer; Paul K Fyfe; Elizabeth Pohler; Silvia Gaggero; Martín López-García; Grant Lythe; Charles Taylor; Thomas Guerrier; David Launay; Suman Mitra; Jacob Piehler; Carmen Molina-París; Ignacio Moraga
Journal:  Elife       Date:  2021-04-19       Impact factor: 8.140

6.  Dysregulation of janus kinases and signal transducers and activators of transcription in cancer.

Authors:  Ana P Costa-Pereira; Nair A Bonito; Michael J Seckl
Journal:  Am J Cancer Res       Date:  2011-06-22       Impact factor: 6.166

7.  Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses.

Authors:  Claire Gorby; Junel Sotolongo Bellón; Stephan Wilmes; Walid Warda; Elizabeth Pohler; Paul K Fyfe; Adeline Cozzani; Christophe Ferrand; Mark R Walter; Suman Mitra; Jacob Piehler; Ignacio Moraga
Journal:  Sci Signal       Date:  2020-09-15       Impact factor: 8.192

8.  Deletion of intestinal epithelial cell STAT3 promotes T-lymphocyte STAT3 activation and chronic colitis following acute dextran sodium sulfate injury in mice.

Authors:  Tara A Willson; Ingrid Jurickova; Margaret Collins; Lee A Denson
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

Review 9.  Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases.

Authors:  Xiaoyu Hu; Lionel B Ivashkiv
Journal:  Immunity       Date:  2009-10-16       Impact factor: 31.745

10.  The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3.

Authors:  Jun Zhang; Jinbo Yang; Sanjit K Roy; Silvia Tininini; Jiadi Hu; Jacqueline F Bromberg; Valeria Poli; George R Stark; Dhananjaya V Kalvakolanu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.